Koala immunology and infectious diseases: How much can the koala bear?

Dev Comp Immunol. 2018 May:82:177-185. doi: 10.1016/j.dci.2018.01.017. Epub 2018 Jan 31.

Abstract

Infectious diseases are contributing to the decline of the iconic Australian marsupial, the koala (Phascolarctos cinereus). Infections with the obligate intracellular bacteria, Chlamydia pecorum, cause debilitating ocular and urogenital-tract disease while the koala-retrovirus (KoRV) has been implicated in host immunosuppression and exacerbation of chlamydial pathogenesis. Although histological studies have provided insight into the basic architecture of koala immune tissues, our understanding of the koala immune response to infectious disease has been limited, until recently, by a lack of species-specific immune reagents. Recent advances in the characterisation of key immune genes have focused on advancing our understanding of the immune response to Chlamydia infection, revealing commonalities in disease pathologies and immunity between koalas and other hosts and paving the way for the development of a koala Chlamydia vaccine. This review summarises these recent findings and highlights key aspects of the koala immune system requiring further attention with particular regard to their most prominent infectious diseases.

Keywords: Chlamydia; Immune system; Koala; Koala retrovirus.

Publication types

  • Review

MeSH terms

  • Animals
  • Australia
  • Bacterial Vaccines / immunology
  • Chlamydia / physiology*
  • Chlamydia Infections / immunology*
  • Communicable Diseases / immunology*
  • Host-Pathogen Interactions
  • Humans
  • Immunity / genetics
  • Immunosuppression Therapy
  • Phascolarctidae / immunology*
  • Retroviridae / physiology*
  • Retroviridae Infections / immunology*
  • Urogenital System / immunology*
  • Urogenital System / microbiology
  • Urogenital System / virology

Substances

  • Bacterial Vaccines